Most peptides obtained outside of a clinical trial or compounding pharmacy setting cannot be guaranteed sterile, pure, or bioactive. CSMR, 2018 Risks of Injecting an Unregulated Compound Patients often reconstitute BPC157 at home using bacteriostatic water (often purchased separately), without understanding: Sterile technique standards are not being met
Animal studies show reduced body fat without impacting IGF-1 or appetite
The fix
99203 - Low complexity new patient visit (may be appropriate for straightforward diabetes or obesity cases without significant comorbidities) 99204 - Moderate complexity new patient visit (appropriate when multiple comorbidities need evaluation, medication reconciliation is complex, or significant counseling is required) 99205 - High complexity new patient visit (appropriate when the patient presents with multiple interacting conditions that complicate tirzepatide prescribing decisions) Established patient follow-up visits Ongoing tirzepatide management visits use established patient E/M codes: 99213 - Low complexity established patient visit (routine dose adjustment, no new concerns) 99214 - Moderate complexity established patient visit (dose escalation decisions, managing side effects like tirzepatide constipation , evaluating treatment response, adjusting concurrent medications) 99215 - High complexity established patient visit (complex management involving multiple interacting conditions, significant medication changes, or management of serious adverse effects) The key to proper E/M coding is documentation
At this stage, many researchers also look at semaglutide reconstitution chart for 10mg vials because the 10mg option lasts longer at higher doses and reduces reconstitution frequency
